Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orlistat

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Empros Pharma AB · Phase 3 · Completed · Enrollment 638

NCT01755676

ArmPopulationDoseWeeksEstimandWeight change
Orlistat 60 mgObesity or overweight60 mgn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r